Pharma

Cosette Pharmaceuticals Acquires Intrarosa, a Drug to Treat Post-Menopausal Vulvovaginal Atrophy

Organon Partners with the Development Bank of Latin America to Increase Sustainable Financing in Women’s Health

Daré Bioscience Reports Positive Results for Its Sildenafil Cream in Women with Sexual Arousal Disorder

FDA Approves Astellas’ VEOZAH for the Treatment of Hot Flashes During Menopause

Pharma Company Bayer Plans to Scale Back Women’s Health R&D

Sumitovant Biopharma Acquires Women’s Health Pharma Company Myovant Sciences for $1.7B

Chugai and Biofourmis Partner to Develop Data-Driven Virtual Care for Endometriosis-Related Pain

New Data Suggests Daré Bioscience’s Intravaginal Ring Can Help Manage Vasomotor and Vaginal Menopause Symptoms

Male Contraception Initiative Invests $800K in Eppin Pharma to Support Clinical Trials for a Non-Hormonal Contraceptive

Biotech: Second Novel PCOS Drug Target from Celmatix-Evotec Alliance Progresses into Hit-Identification

Women’s Health Company TherapeuticsMD Signs Product Licensing Agreement with Mayne Pharma

Sebela Pharmaceuticals Launches a New Division Dedicated to Women’s Health

Bayer’s Mirena IUD Is Now Approved for Pregnancy Prevention for Up to 8 Years

Myovant Sciences and Pfizer Receive FDA Approval of MYFEMBREE, a Once-Daily Endometriosis Treatment

Daré Bioscience Signs Agreement with Organon for Bacterial Vaginosis Therapy

Organon Signs a Licensing Deal with Henlius for Biosimilars Targeting Osteoporosis and Breast Cancer

Carlyle and PAI Partners Agree to Acquire Women’s Health Pharma Company Theramex

Women’s Health Pharma Company ObsEva Sells Regional Rights to Its Uterine Fibroid Drug Linzagolix to Theramex

Ferring Invests in Fertility Platform Robyn with the Option to Acquire the Company

Ferring Introduces a New Grant Program to Tackle Gender, Health and Racial Inequalities

Theramex Enters the OTC Market with Femarelle, a Non-hormonal Option to Treat Menopause Symptoms

Organon Announces Plans to Acquire Forendo Pharma, a Biotech Company Targeting Endometriosis and PCOS

Antiva Biosciences Raises a $31M Series D to Take its HPV Drug into Clinical Trials

Women’s Health Pharma Company Organon Launches a New Fertility Journey Website